M. Carrington and S. J. O'brien, The influence of HLA genotype on AIDS, Annu Rev Med, vol.54, pp.535-551, 2003.

J. Fellay, A whole-genome association study of major determinants for host control of HIV-1, Science, vol.317, issue.5840, pp.944-947, 2007.

. International-hiv-controllers and . Study, The major genetic determinants of HIV-1 control affect HLA class I peptide presentation, Science, vol.330, issue.6010, pp.1551-1557, 2010.

X. Gao, AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis, Nat Med, vol.11, issue.12, pp.1290-1292, 2005.

R. A. Kaslow, Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection, Nat Med, vol.2, issue.4, pp.405-411, 1996.

P. Kiepiela, Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA, Nature, vol.432, issue.7018, pp.769-775, 2004.

M. Magierowska, Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals, Blood, vol.93, issue.3, pp.936-941, 1999.

S. A. Migueles, HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors, Proc Natl Acad Sci, vol.97, issue.6, pp.2709-2714, 2000.

X. Gao, Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS, N Engl J Med, vol.344, issue.22, pp.1668-1675, 2001.

S. G. Deeks and B. D. Walker, Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy, Immunity, vol.27, issue.3, pp.406-416, 2007.

B. Emu, HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control, J Virol, vol.82, issue.11, pp.5398-5407, 2008.

G. M. Gillespie, Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57, AIDS, vol.16, issue.7, pp.961-972, 2002.

P. J. Goulder, Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection, AIDS Res Hum Retroviruses, vol.12, issue.18, pp.1691-1698, 1996.

P. Kiepiela,

+. , cell responses to different HIV proteins have discordant associations with viral load, Nat Med, vol.13, issue.1, pp.46-53, 2007.

M. A. Brockman, Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A, J Virol, vol.81, issue.22, pp.12608-12618, 2007.

H. Crawford, Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients, J Exp Med, vol.206, issue.4, pp.909-921, 2009.

A. J. Leslie, HIV evolution: CTL escape mutation and reversion after transmission, Nat Med, vol.10, issue.3, pp.282-289, 2004.

J. Martinez-picado, Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1, J Virol, vol.80, issue.7, pp.3617-3623, 2006.

T. Miura, HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition, J Virol, vol.83, issue.6, pp.2743-2755, 2009.
DOI : 10.1128/jvi.00579-09
URL : http://europepmc.org/articles/pmc2681925?pdf=render

J. M. Carlson, Impact of pre-adapted HIV transmission, Nat Med, vol.22, issue.6, pp.606-613, 2016.

E. L. Turnbull, HIV-1 epitope-specific CD8

, + T cell responses strongly associated with delayed disease progression crossrecognize epitope variants efficiently, J Immunol, vol.176, issue.10, pp.6130-6146, 2006.

A. Kosmrlj, Effects of thymic selection of the T-cell repertoire on HLA class Iassociated control of HIV infection, Nature, vol.465, issue.7296, pp.350-354, 2010.

D. Sharma, Dimorphic motifs in D0 and D1+D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A*2402, J Immunol, vol.183, issue.7, pp.4569-4582, 2009.

C. M. Gardiner, Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism, J Immunol, vol.166, issue.5, pp.2992-3001, 2001.

M. J. Pando, C. M. Gardiner, M. Gleimer, K. L. Mcqueen, and P. Parham, The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1, J Immunol, vol.171, issue.12, pp.6640-6649, 2003.

M. P. Martin, Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS, Nat Genet, vol.31, issue.4, pp.429-434, 2002.

M. P. Martin, Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1, Nat Genet, vol.39, issue.6, pp.733-740, 2007.

K. Pelak, Copy number variation of KIR genes influences HIV-1 control, PLoS Biol, vol.9, issue.11, p.1001208, 2011.

D. Chessman, Human leukocyte antigen class I-restricted activation of CD8

, + T cells provides the immunogenetic basis of a systemic drug hypersensitivity, Immunity, vol.28, issue.6, pp.822-832, 2008.

P. T. Illing, Immune self-reactivity triggered by drug-modified HLA-peptide repertoire, Nature, vol.486, issue.7404, pp.554-558, 2012.

S. Mallal, Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir, Lancet, vol.359, issue.9308, pp.727-732, 2002.

M. A. Norcross, Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity, AIDS, vol.26, issue.11, pp.21-29, 2012.

J. P. Vivian, Killer cell immunoglobulinlike receptor 3DL1-mediated recognition of human leukocyte antigen B, Nature, vol.479, issue.7373, pp.401-405, 2011.

H. Chen, TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection, Nat Immunol, vol.13, issue.7, pp.691-700, 2012.

, 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults, MMWR Recomm Rep, vol.41, issue.17, pp.1-19, 1992.

S. A. Migueles, The differential ability of HLA B*5701 + long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences, J Virol, vol.77, issue.12, pp.6889-6898, 2003.

M. Cella, A. Longo, G. B. Ferrara, J. L. Strominger, and M. Colonna, NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80, J Exp Med, vol.180, issue.4, pp.1235-1242, 1994.
DOI : 10.1084/jem.180.4.1235
URL : http://jem.rupress.org/content/180/4/1235.full.pdf

J. E. Boudreau, T. J. Mulrooney, L. Luduec, J. B. Barker, E. Hsu et al., KIR3DL1 and HLA-B density and binding calibrate NK education and response to HIV, J Immunol, vol.196, issue.8, pp.3398-3410, 2016.
DOI : 10.4049/jimmunol.1502469
URL : http://www.jimmunol.org/content/196/8/3398.full.pdf

J. E. Gumperz, Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor, J Immunol, vol.158, issue.11, pp.5237-5241, 1997.

P. M. Saunders, Killer cell immunoglobulinlike receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition, J Exp Med, vol.213, issue.5, pp.791-807, 2016.

G. M. O'connor, Mutational and structural analysis of KIR3DL1 reveals a lineagedefining allotypic dimorphism that impacts both HLA and peptide sensitivity, J Immunol, vol.192, issue.6, pp.2875-2884, 2014.

P. J. Norman, Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans, Nat Genet, vol.39, issue.9, pp.1092-1099, 2007.

S. Rojo, N. Wagtmann, and E. O. Long, Binding of a soluble p70 killer cell inhibitory receptor to HLA-B*5101: requirement for all three p70 immunoglobulin domains, Eur J Immunol, vol.27, issue.2, pp.568-571, 1997.

S. I. Khakoo, R. Geller, S. Shin, J. A. Jenkins, and P. Parham, The D0 domain of KIR3D acts as a major histocompatibility complex class I binding enhancer, J Exp Med, vol.196, issue.7, pp.911-921, 2002.

S. , Structures of three HIV-1 HLA-B*5703-peptide complexes and identification of related HLAs potentially associated with long-term nonprogression, J Immunol, vol.175, issue.4, pp.2459-2468, 2005.

J. Phair, Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: the

C. Multicenter and . Study, J Acquir Immune Defic Syndr, vol.5, issue.5, pp.490-496, 1992.

D. Vlahov, The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants, NIDA Res Monogr, vol.109, pp.75-100, 1991.

B. Emu, Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment, J Virol, vol.79, issue.22, pp.14169-14178, 2005.

S. A. Migueles, HIV-specific CD8

, + T cell proliferation is coupled to perforin expression and is maintained in nonprogressors, Nat Immunol, vol.3, issue.11, pp.1061-1068, 2002.

C. L. Holcomb, A multi-site study using high-resolution HLA genotyping by next generation sequencing, Tissue Antigens, vol.77, issue.3, pp.206-217, 2011.

M. P. Martin and M. Carrington, KIR locus polymorphisms: genotyping and disease association analysis, Methods Mol Biol, vol.415, pp.49-64, 2008.
DOI : 10.1007/978-1-59745-570-1_3

R. Thomas, Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation?, J Immunol, vol.180, issue.10, pp.6743-6750, 2008.

C. S. Clements, The production, purification and crystallization of a soluble heterodimeric form of a highly selected T-cell receptor in its unliganded and liganded state, Acta Crystallogr D Biol Crystallogr, vol.58, pp.2131-2134, 2002.

C. J. Barnstable, Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis, Cell, vol.14, issue.1, pp.9-20, 1978.